Sponsors of clinical trials in the United States have a regulatory responsibility under 21 CFR Part 312.50 to monitor the progress of clinical studies. Historically, Sponsors performed in-person ...

Technology has enabled clinical medicine to adapt remarkably during the COVID-19 pandemic. Through virtual clinic visits, telehealth has allowed clinicians to evaluate and treat patients while ...

Siwen Hu-Lieskovan, PhD, MD, physician scientist at Huntsman Cancer Institute (HCI) and assistant professor of medicine at the University of Utah, has received the National Cancer Institute (NCI) 2020 ...

If technology companies want to make a positive impact on healthcare, they need to explore ways to make clinical trials more accessible and efficient. Faster, more inclusive clinical trials lead to ...

Despite robust product development efforts, there is still a considerable gap between patients and physicians needed in clinical research and those actually participating. The recent shift and ...

All protocols reviewed by the IRB are subject to regulatory monitoring by the IRB and OIRB personnel. Studies are selected at random as well as according to criteria listed in the UAB Policy and ...

Huntsman Mental Health Institute is pleased to celebrate Rana Jawish, MD, and Ben Lewis, MD, who were named recipients of the 2024 New Investigator Award from the American Society of Clinical ...

Clinical trials are an essential component of the research architecture for developing new drugs and devices. Research institutions and their clinical investigators (“Investigators”) play an important ...

Investigator-initiated trials (IITs) have progressively shifted from specialized academic projects to become a key driver of contemporary clinical research. Previously deemed small-scale or ...

Our clinical research units aim to facilitate timely and responsible completion of human studies from conception through completion and effectively disseminate key findings through responsible and ...

Recruitment is one of the greatest challenges — and opportunities — for researchers. Reaching potential participants for clinical trials has always been a complex process, and the COVID-19 pandemic ...